Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Thoracic Surgery

Free Subscription Articles published in Am Heart J Retrieve available abstracts of 92 articles: HTML format Text format

Single Articles

January 2012
1. FERRANTE G , Presbitero P, Corrada E, Campo G, et al
   Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofi
   Am Heart J. 2012;163:104-11.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. LAMY A , Devereaux PJ, Prabhakaran D, Hu S, et al
   Rationale and design of The Coronary Artery Bypass Grafting Surgery Off or On Pump Revascularization Study: A large international randomized trial in cardiac surgery.
   Am Heart J. 2012;163:1-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. SHIVARAJU A , Patel V, Fonarow GC, Xie H, et al
   Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: Analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database.
   Am Heart J. 2011;162:1062-1068.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. CHIN CT , Weintraub WS, Dai D, Mehta RH, et al
   Trends and predictors of length of stay after primary percutaneous coronary intervention: A report from the CathPCI Registry.
   Am Heart J. 2011;162:1052-61.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. BRENER SJ , Cristea E, Mehran R, Dressler O, et al
   Relationship between angiographic dynamic and densitometric assessment of myocardial reperfusion and survival in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: The Harmonizing Outcomes with Revascula
   Am Heart J. 2011;162:1044-51.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. HAHN JY , Kim HJ, Choi YJ, Jo SH, et al
   Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
   Am Heart J. 2011;162:1026-33.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
7. JONES WS , Patel MR, Holleran SA, Harrison JK, et al
   Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina.
   Am Heart J. 2011;162:932-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. STOLKER JM , Cohen DJ, Lindsey JB, Kennedy KF, et al
   Mode of death after contemporary percutaneous coronary intervention: A report from the Evaluation of Drug Eluting Stents and Ischemic Events registry.
   Am Heart J. 2011;162:914-21.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. KALAVROUZIOTIS D , Buth KJ, Cox JL, Baskett RJ, et al
   Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and beta-blockers after coronary artery bypass graft surgery.
   Am Heart J. 2011;162:836-43.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. MAURI L , Normand SL, Pencina M, Cutlip DE, et al
    Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site.
    Am Heart J. 2011;162:826-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. GUTIERREZ-CHICO JL , Juni P, Garcia-Garcia HM, Regar E, et al
    Long-term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer.
    Am Heart J. 2011;162:922-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. PUYMIRAT E , Mangiacapra F, Peace A, Sharif F, et al
    Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting.
    Am Heart J. 2011;162:907-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
13. SCHWARZ N , Schoenburg M, Mollmann H, Kastaun S, et al
    Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting.
    Am Heart J. 2011;162:756-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. KELLY DJ , Gershlick T, Witzenbichler B, Guagliumi G, et al
    Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: The HORIZONS-AMI trial.
    Am Heart J. 2011;162:663-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. POVSIC TJ , O'Connor CM, Henry T, Taussig A, et al
    A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction.
    Am Heart J. 2011;162:654-662.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
16. PARIKH PB , Gruberg L, Jeremias A, Chen JJ, et al
    Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention.
    Am Heart J. 2011;162:512-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. IMAZIO M , Brucato A, Rovere ME, Gandino A, et al
    Colchicine prevents early postoperative pericardial and pleural effusions.
    Am Heart J. 2011;162:527-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. KESSLER DP , Kroch E, Hlatky MA
    The effect of bivalirudin on costs and outcomes of treatment of ST-segment elevation myocardial infarction.
    Am Heart J. 2011;162:494-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. LAI CT , Chan KW, Wong SJ, Chow PC, et al
    Circulating levels of biomarkers of collagen synthesis and ventricular function and dyssynchrony in adolescents and young adults after repair of tetralogy of Fallot.
    Am Heart J. 2011;162:467-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. ATZEMA CL , Schull MJ, Austin PC, Tu JV, et al
    Temporal changes in emergency department triage of patients with acute myocardial infarction and the effect on outcomes.
    Am Heart J. 2011;162:451-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. SALA C , Grau M, Masia R, Vila J, et al
    Trends in Q-wave acute myocardial infarction case fatality from 1978 to 2007 and analysis of the effectiveness of different treatments.
    Am Heart J. 2011;162:444-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. TYMCHAK W , Armstrong PW, Westerhout CM, Sookram S, et al
    Mode of hospital presentation in patients with non-ST-elevation myocardial infarction: Implications for strategic management.
    Am Heart J. 2011;162:436-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ALMOND CS , Buchholz H, Massicotte P, Ichord R, et al
    Berlin Heart EXCOR Pediatric ventricular assist device Investigational Device Exemption study: study design and rationale.
    Am Heart J. 2011;162:425-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
24. VARENHORST C , Koul S, Erlinge D, Lagerqvist B, et al
    Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-A case-control study.
    Am Heart J. 2011;162:363-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. RAMANATHAN K , Farkouh ME, Cosmi JE, French JK, et al
    Rapid complete reversal of systemic hypoperfusion after intra-aortic balloon pump counterpulsation and survival in cardiogenic shock complicating an acute myocardial infarction.
    Am Heart J. 2011;162:268-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. ELBAROUNI B , Ismaeil N, Yan RT, Fox KA, et al
    Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
    Am Heart J. 2011;162:347-355.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. GOTZMANN M , Pljakic A, Bojara W, Lindstaedt M, et al
    Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response.
    Am Heart J. 2011;162:238-245.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. GEORGIADOU P , Kontodima P, Sbarouni E, Karavolias GK, et al
    Long-term quality of life improvement after transcatheter aortic valve implantation.
    Am Heart J. 2011;162:232-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
29. WU J , Pride YB, Frederick PD, Gibson CM, et al
    Association of initial Thrombolysis in Myocardial Infarction flow grade with mortality among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: A National Registry of Myocardial Infarction-5
    Am Heart J. 2011;162:178-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. CRISTEA E , Stone GW, Mehran R, Kirtane AJ, et al
    Changes in reference vessel diameter in ST-segment elevation myocardial infarction after primary percutaneous coronary intervention: Implications for appropriate stent sizing.
    Am Heart J. 2011;162:173-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. FRENCH JK , Armstrong PW, Cohen E, Kleiman NS, et al
    Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: Observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
    Am Heart J. 2011;162:89-97.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. PATEL MR , Thiele H, Smalling RW, Chandra P, et al
    A multicenter, randomized, controlled study of mechanical left ventricular unloading with counterpulsation to reduce infarct size prepercutaneous coronary intervention for acute myocardial infarction: Rationale and design of the Counterpulsation Reduc
    Am Heart J. 2011;162:47-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. LIN GM , Li YH, Chu KM, Han CL, et al
    Standard versus high loading doses of clopidogrel in Asian patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry.
    Am Heart J. 2011;162:e17.
    PubMed     Text format     Related articles   
    
    
    
    
34. CHUNG SC , Hlatky MA, Stone RA, Rana JS, et al
    Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D).
    Am Heart J. 2011;162:184-192.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. NOROZI K , Buchhorn R, Yasin A, Geyer S, et al
    Growth differentiation factor 15: An additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects?
    Am Heart J. 2011;162:131-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. BANKA P , Sleeper LA, Atz AM, Cowley CG, et al
    Practice variability and outcomes of coil embolization of aortopulmonary collaterals before Fontan completion: a report from the Pediatric Heart Network Fontan Cross-Sectional Study.
    Am Heart J. 2011;162:125-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. MOZAFFARIAN D , Marchioli R, Gardner T, Ferrazzi P, et al
    The omega-3 fatty acids for Prevention of Post-Operative Atrial Fibrillation trial-rationale and design.
    Am Heart J. 2011;162:56-63.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. RAPOSEIRAS-ROUBIN S , Pardal CB, Ocaranza R, Cid B, et al
    Acute hyperglycemia: Is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
    Am Heart J. 2011;162:e7.
    PubMed     Text format     Related articles   
    
    
    
    
39. CIKIRIKCIOGLU M , Cherian S, Schussler O, Kalangos A, et al
    Regarding "The EVEREST II Trial: Design and rationale for a randomized study of the Evalve MitraClip system compared with mitral valve surgery for mitral regurgitation".
    Am Heart J. 2011;162:e11-2.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
40. PRADA-DELGADO O , Estevez-Loureiro R, Calvino-Santos R, Barge-Caballero E, et al
    Safety and efficacy of femoral vascular closure devices in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Am Heart J. 2011;161:1207-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. SZEKELY A , Nussmeier NA, Miao Y, Huang K, et al
    A multinational study of the influence of health-related quality of life on in-hospital outcome after coronary artery bypass graft surgery.
    Am Heart J. 2011;161:1179-1185.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. YAMAMOTO M , Takano M, Murakami D, Inami T, et al
    The possibility of delayed arterial healing 5 years after implantation of sirolimus-eluting stents: serial observations by coronary angioscopy.
    Am Heart J. 2011;161:1200-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. YUSUF SW , Sarfaraz A, Durand JB, Swafford J, et al
    Management and outcomes of severe aortic stenosis in cancer patients.
    Am Heart J. 2011;161:1125-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. WENAWESER P , Pilgrim T, Roth N, Kadner A, et al
    Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes.
    Am Heart J. 2011;161:1114-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. PONTONE G , Andreini D, Bartorelli AL, Annoni A, et al
    Feasibility and accuracy of a comprehensive multidetector computed tomography acquisition for patients referred for balloon-expandable transcatheter aortic valve implantation.
    Am Heart J. 2011;161:1106-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
46. LEE DS , Verocai F, Husain M, Al Khdair D, et al
    Cardiovascular outcomes are predicted by exercise-stress myocardial perfusion imaging: Impact on death, myocardial infarction, and coronary revascularization procedures.
    Am Heart J. 2011;161:900-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. ALI S , Goodman SG, Yan RT, Budaj A, et al
    Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes.
    Am Heart J. 2011;161:878-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. BURKE MA , Lee R, Fintel DJ
    Early clopidogrel use in non-ST elevation acute coronary syndrome and subsequent coronary artery bypass grafting.
    Am Heart J. 2011;161:832-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. MAURI L , Leon MB, Yeung AC, Negoita M, et al
    Rationale and design of the clinical evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the treatment of de novo lesions in native coronary arteries (the RESOLUTE US clinical trial).
    Am Heart J. 2011;161:807-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. SUN JC
    Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: The Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
    Am Heart J. 2011;161:e27.
    PubMed     Text format     Related articles   
    
    
    
    
51. REFIKER M
    Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: The Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting surgery.
    Am Heart J. 2011;161:e25.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
52. MEHTA RH , Starr AZ, Lopes RD, Piccini JP, et al
    Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk.
    Am Heart J. 2011;161:782-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. MAGRO M , Nauta S, Simsek C, Onuma Y, et al
    Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study.
    Am Heart J. 2011;161:771-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. KO DT , Atzema CL, Donovan LR, Graham MM, et al
    Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial infarction: A population-based study.
    Am Heart J. 2011;161:764-770.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. MONTALESCOT G , Bolognese L, Dudek D, Goldstein P, et al
    A Comparison of prasugrel at the time of percutaneous Coronary intervention or as pretreatment at the time of diagnosis in patients with non-ST-segment elevation myocardial infarction: Design and rationale for the ACCOAST study.
    Am Heart J. 2011;161:650-656.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. ELHMIDI Y , Bleiziffer S, Piazza N, Hutter A, et al
    Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2011;161:735-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. BAGUR R , Rodes-Cabau J, Dumont E, De Larochelliere R, et al
    Performance-based functional assessment of patients undergoing transcatheter aortic valve implantation.
    Am Heart J. 2011;161:726-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. NEWELL MC , Henry JT, Henry TD, Duval S, et al
    Impact of age on treatment and outcomes in ST-elevation myocardial infarction.
    Am Heart J. 2011;161:664-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
59. UDELSON JE , Pearte CA, Kimmelstiel CD, Kruk M, et al
    The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): Influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone.
    Am Heart J. 2011;161:611-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. KUKULA K , Chojnowska L, Dabrowski M, Witkowski A, et al
    Intramyocardial plasmid-encoding human vascular endothelial growth factor A165/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD).
    Am Heart J. 2011;161:581-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. ARAGAM KG , Moscucci M, Smith DE, Riba AL, et al
    Trends and disparities in referral to cardiac rehabilitation after percutaneous coronary intervention.
    Am Heart J. 2011;161:544-551.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. DE BOER SP , Barnes EH, Westerhout CM, Simes RJ, et al
    High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: Results from the Primary Coronary Angioplasty Trialist versus Thrombolysis (PCAT)-2 Collaboration.
    Am Heart J. 2011;161:500-507.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. GIBSON CM , Maehara A, Lansky AJ, Wohrle J, et al
    Rationale and design of the INFUSE-AMI study: A 2 x 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST
    Am Heart J. 2011;161:478-486.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. CAPODANNO D , Tamburino C
    Integrating the Synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery (SYNTAX) score into practice: Use, pitfalls, and new directions.
    Am Heart J. 2011;161:462-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. GURBEL PA , Shuldiner AR, Bliden KP, Ryan K, et al
    The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy.
    Am Heart J. 2011;161:598-604.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. WHITE HD
    Oral antiplatelet therapy for atherothrombotic disease: current evidence and new directions.
    Am Heart J. 2011;161:450-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
67. CRUDEN NL , Morch K, Wong DR, Klinke WP, et al
    Clopidogrel loading dose and bleeding outcomes in patients undergoing urgent coronary artery bypass grafting.
    Am Heart J. 2011;161:404-10.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. HOLPER EM , Abbott JD, Mulukutla S, Vlachos H, et al
    Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry.
    Am Heart J. 2011;161:397-403.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. KO YG , Suh JW, Kim BH, Lee CJ, et al
    Comparison of 2 point-of-care platelet function tests, VerifyNow Assay and Multiple Electrode Platelet Aggregometry, for predicting early clinical outcomes in patients undergoing percutaneous coronary intervention.
    Am Heart J. 2011;161:383-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. CHOI CU , Rha SW, Oh DJ, Poddar KL, et al
    Standard versus high loading doses of clopidogrel in Asian ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention: Insights from the Korea Acute Myocardial Infarction Registry.
    Am Heart J. 2011;161:373-382.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. WESTERHOUT CM , Bonnefoy E, Welsh RC, Steg PG, et al
    The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: A pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST.
    Am Heart J. 2011;161:283-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. POVSIC TJ , Cohen MG, Mehran R, Buller CE, et al
    A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: Design and rationale of the RADAR Ph
    Am Heart J. 2011;161:261-268.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. JOLLY SS , Niemela K, Xavier D, Widimsky P, et al
    Design and rationale of the RadIal Vs. femorAL access for coronary intervention (RIVAL) trial: A randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes.
    Am Heart J. 2011;161:254-260.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. TARANTINI G , Van de Werf F, Bilato C, Gersh B, et al
    Primary percutaneous coronary intervention for acute myocardial infarction: Is it worth the wait? The risk-time relationship and the need to quantify the impact of delay.
    Am Heart J. 2011;161:247-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. JAVED U , Deedwania PC, Bhatt DL, Cannon CP, et al
    Use of intensive lipid-lowering therapy in patients hospitalized with acute coronary syndrome: An analysis of 65,396 hospitalizations from 344 hospita participating in Get With The Guidelines (GWTG).
    Am Heart J. 2011;161:418-424.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. LONGMUIR PE , Russell JL, Corey M, Faulkner G, et al
    Factors associated with the physical activity level of children who have the Fontan procedure.
    Am Heart J. 2011;161:411-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. HAKIM DA , Dangas GD, Caixeta A, Nikolsky E, et al
    Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: Analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORI
    Am Heart J. 2011;161:391-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
78. TRIVEDI B , Smith PB, Barker PC, Jaggers J, et al
    Arrhythmias in patients with hypoplastic left heart syndrome.
    Am Heart J. 2011;161:138-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. GIN A , Hong H, Rosenblatt A, Black M, et al
    Pseudoaneurysms of the mitral-aortic intervalvular fibrosa: survival without reoperation.
    Am Heart J. 2011;161:130.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. CHIN CT , Chen AY, Wang TY, Alexander KP, et al
    Risk adjustment for in-hospital mortality of contemporary patients with acute myocardial infarction: The Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry((R))-Get With The Guidelines (GWTG) acute myocardial infarction morta
    Am Heart J. 2011;161:113-122.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. KAUL P , Armstrong PW, Sookram S, Leung BK, et al
    Temporal trends in patient and treatment delay among men and women presenting with ST-elevation myocardial infarction.
    Am Heart J. 2011;161:91-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. DEVLIN G , Reynolds HR, Mark DB, Rankin JM, et al
    Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).
    Am Heart J. 2011;161:84-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. NDREPEPA G , Braun S, Mehilli J, Birkmeier KA, et al
    Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin.
    Am Heart J. 2011;161:68-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. COLLET JP , Cayla G, Cuisset T, Elhadad S, et al
    Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: rationale and design of the assessment with a double randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and clopido
    Am Heart J. 2011;161:5-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
85. EWE SH , Ajmone Marsan N, Pepi M, Delgado V, et al
    Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis.
    Am Heart J. 2010;160:1113-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. RAEDLE-HURST TM , Koenigstein K, Gruenhage F, Raedle J, et al
    Growth differentiation factor 15--an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts.
    Am Heart J. 2010;160:1105-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. COHEN MS , Zak V, Atz AM, Printz BF, et al
    Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome.
    Am Heart J. 2010;160:1092-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. FROBERT O , Lagerqvist B, Gudnason T, Thuesen L, et al
    Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design
    Am Heart J. 2010;160:1042-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. PORTO I , Hamilton-Craig C, Brancati M, Burzotta F, et al
    Angiographic assessment of microvascular perfusion-Myocardial blush in clinical practice.
    Am Heart J. 2010;160:1015-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
90. HASSAN A , Newman A, Ko DT, Rinfret S, et al
    Increasing rates of angioplasty versus bypass surgery in Canada, 1994-2005.
    Am Heart J. 2010;160:958-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. SHERIF MA , Abdel-Wahab M, Awad O, Geist V, et al
    Early hemodynamic and neurohormonal response after transcatheter aortic valve implantation.
    Am Heart J. 2010;160:862-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. KONTOS MC , de Lemos JA, Ou FS, Wiviott SD, et al
    Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get Wit
    Am Heart J. 2010;160:819-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: